Loading the map…
Private limited company registered in Leeds, classed under “Advertising agencies” and 2 other activities.
Headline figures
FY to May 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Profit marginProfit after tax as a share of turnover | ||||
| Return on equityProfit after tax as a share of net assets | ||||
| Turnover per employeeTurnover divided by average staff | ||||
3 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Skyron Health do?
Private limited company registered in Leeds, classed under “Advertising agencies” and 2 other activities.
›How much turnover does Skyron Health make?
Answered in the full report
›Is Skyron Health profitable?
Skyron Health's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Skyron Health?
Answered in the full report
›Where is Skyron Health based?
Its registered office is 79 Old Park Road, Flat 3, Leeds, LS8 1JB, in Leeds.
›When was Skyron Health founded?
Skyron Health Ltd was incorporated on 1 May 2018.
›Is Skyron Health still trading?
The register lists Skyron Health Ltd as active.